VNS Therapy™ is a neuromodulation treatment designed for people with drug-resistant epilepsy 4 years of age and older with partial onset seizures. It can safely lead to fewer and shorter seizures and better recovery after seizures and has been shown to offer quality-of-life benefits that can help patients overcome obstacles they face in everyday life.
VNS Therapy™ stimulates the vagus nerve, sending mild electrical pulses to the brain to help prevent seizures. Uses an implantable generator and lead and can be programmed to fit the needs of each patient. Unlike invasive brain surgeries, VNS Therapy™ involves a short outpatient procedure that usually takes 1 to 2 hours. Treatment is delivered automatically, maximizing adherence for optimal seizure control
AspireSR™ – Advancing the treatment of drug-resistant epilepsy
-
- Provides the proven efficacy and safety of VNS Therapy
- Detects and responds to ictal tachycardia in an effort to stop seizures spreading in the brain
- May terminate seizures by delivering automatic stimulation when a seizure occurs
- May reduce seizure duration and seizure severity and improve post-ictal recovery
- Improves quality of life
AspireSR™ detects and responds to rapid increases in heart rate, which may be associated with a seizure
-
- In clinical trials, over 60% of seizures treated ended during automatic stimulation.
- The closer the stimulation to seizure onset, the shorter the seizure duration